hdac6 d2e5 Search Results


anti hdac6 d2e5  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc anti hdac6 d2e5
Anti Hdac6 D2e5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/HDAC6+Rabbit+mAb/pmc11586521-196-35-38
Average 95 stars, based on 1 article reviews
anti hdac6 d2e5 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
hdac6 rabbit mab  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc hdac6 rabbit mab
Hdac6 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/HDAC6+Rabbit+mAb/pmc05214232-512-18-30
Average 95 stars, based on 1 article reviews
hdac6 rabbit mab - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
integrin β1  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc integrin β1
Integrin β1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/Integrin+beta1+Antibody/ppr0396779-76-19-25
Average 96 stars, based on 1 article reviews
integrin β1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
7628s hdac6 d2e5 cell signaling  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc 7628s hdac6 d2e5 cell signaling
a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d <t>HDAC6</t> has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland
7628s Hdac6 D2e5 Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/HDAC4+Rabbit+mAb/pmc07669913-84-73-76
Average 95 stars, based on 1 article reviews
7628s hdac6 d2e5 cell signaling - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
hdac6 d2e5 rabbit mab  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc hdac6 d2e5 rabbit mab
a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d <t>HDAC6</t> has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland
Hdac6 D2e5 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/SirT1+Rabbit+mAb/pmc07359080-19-53-56
Average 96 stars, based on 1 article reviews
hdac6 d2e5 rabbit mab - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
ampar1  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc ampar1
a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d <t>HDAC6</t> has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland
Ampar1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/AMPA+Receptor+1+(GluA1)+Rabbit+mAb/ppr0609334-228-103-104
Average 96 stars, based on 1 article reviews
ampar1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
hdac6  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc hdac6
a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d <t>HDAC6</t> has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland
Hdac6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac6+d2e5/HDAC6+Rabbit+mAb/10__1096_slash_fj__202002138rr-53-22-28
Average 93 stars, based on 1 article reviews
hdac6 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d HDAC6 has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland

Journal: Head and Neck Pathology

Article Title: HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report

doi: 10.1007/s12105-020-01130-6

Figure Lengend Snippet: a HDAC2 is strongly and diffusely expressed in all tumour nuclei, but weakly so in reactive lymphocytes’ and the parotid gland’s. b, c HDAC4 and pHDAC457 have a strong and diffuse cytoplasmic expression in all tumour cells as well as in reactive lymphocytes, but not in the parotid gland. d HDAC6 has a diffuse cytoplasmic expression in all tumour cells, stronger than in reactive lymphocytes and in the parotid gland

Article Snippet: The technical details of the antibodies are specified in Table . table ft1 table-wrap mode="anchored" t5 Table 2 caption a7 Target Clone Manufacturer Dilution Catalog number NUT C52B1 Cell signaling 1:10 3625S MYC Y69 Ventana Prediluted 790–4628 P53 DO7 Cell marque 1:150 453 M HDAC1 10E2 Cell signaling 1:2500 5356P HDAC2 3F3 Cell signaling 1:200 5113P HDAC3 7G6C5 Cell signaling 1:400 3949S pHDAC3 S424 Cell signaling 1:150 3815S HDAC4 D15C3 Cell signaling 1:400 7628S HDAC6 D2E5 Cell signaling 1:500 7558P HDAC7 D4E1L Cell signaling 1:400 33418S HDAC8 Polyclonal Atlas antibodies 1:250 HPA048560 pHDAC457 S246, S259 and S155 Cell signaling 1:300 3443P Open in a separate window Technical specifications of the antibodies used

Techniques: Expressing

Technical specifications of the antibodies used

Journal: Head and Neck Pathology

Article Title: HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report

doi: 10.1007/s12105-020-01130-6

Figure Lengend Snippet: Technical specifications of the antibodies used

Article Snippet: The technical details of the antibodies are specified in Table . table ft1 table-wrap mode="anchored" t5 Table 2 caption a7 Target Clone Manufacturer Dilution Catalog number NUT C52B1 Cell signaling 1:10 3625S MYC Y69 Ventana Prediluted 790–4628 P53 DO7 Cell marque 1:150 453 M HDAC1 10E2 Cell signaling 1:2500 5356P HDAC2 3F3 Cell signaling 1:200 5113P HDAC3 7G6C5 Cell signaling 1:400 3949S pHDAC3 S424 Cell signaling 1:150 3815S HDAC4 D15C3 Cell signaling 1:400 7628S HDAC6 D2E5 Cell signaling 1:500 7558P HDAC7 D4E1L Cell signaling 1:400 33418S HDAC8 Polyclonal Atlas antibodies 1:250 HPA048560 pHDAC457 S246, S259 and S155 Cell signaling 1:300 3443P Open in a separate window Technical specifications of the antibodies used

Techniques: